Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
0 %
$ 37.9 M
Market Cap
-0.64
P/E
ANTX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ANTX - AN2 Therapeutics, Inc.
275 K
LAST VALUE
249.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR